marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 14.11.2024
Aileron Therapeutics Bilanz 2011-2024 | ALRN
Bilanz Jährlich Aileron Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
- | - | -3.44 M | -6.66 M | -279 K | -5.29 M | -11.9 M | -20.7 M | -3.77 M | - | - | - | - |
Langfristige Schulden |
- | - | 69 K | 219 K | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
48 K | 33 K | 93 K | - | 446 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 4.59 M | 5.34 M | - | 130 M | 97.7 M | - | - | - | - |
Kurzfristige Verbindlichkeiten |
4.38 M | 3.38 M | 4.51 M | 3.96 M | 5.84 M | 5.37 M | 4.89 M | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
7.71 M | 3.38 M | 4.58 M | 4.18 M | 10.4 M | 10.7 M | 4.89 M | 134 M | 100 M | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-289 M | -273 M | -245 M | -219 M | -198 M | -168 M | -137 M | -114 M | -96.2 M | - | - | - | - |
Vermögenswerte |
106 M | 22 M | 48.5 M | 16.3 M | 26.5 M | 30.3 M | 52.7 M | 22 M | 5.94 M | - | - | - | - |
Zahlungsmittel |
17.3 M | 5.19 M | 3.6 M | 7.05 M | 5.31 M | 10.6 M | 11.9 M | - | - | - | - | - | - |
Buchwert |
98.3 M | 18.6 M | 43.9 M | 12.2 M | 16 M | 19.6 M | 47.8 M | -112 M | -94.3 M | - | - | - | - |
Gesamtes Eigenkapital |
6.89 M | 18.6 M | 43.9 M | 12.2 M | 16 M | 19.6 M | 47.8 M | -112 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Aileron Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | - | - | 69 K | 99 K | 128 K | 124 K | - | 4.2 M | 4.33 M | 4.46 M | 4.59 M | 4.59 M | 4.59 M | 4.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
8.98 M | 8.38 M | 7.86 M | 7.71 M | 1.62 M | 1.2 M | 2.88 M | 3.38 M | 4.54 M | 5.15 M | 4.15 M | 4.58 M | 4.66 M | 4.4 M | 3.25 M | 4.18 M | 4.18 M | 4.18 M | 4.18 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 4.89 M | 4.89 M | 4.89 M | 4.89 M | 4.08 M | 4.08 M | 4.08 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-310 M | -305 M | -296 M | -289 M | -281 M | -279 M | -278 M | -273 M | -268 M | -262 M | -254 M | -245 M | -239 M | -232 M | -226 M | -219 M | -219 M | -219 M | -219 M | -198 M | -198 M | -198 M | -198 M | -168 M | -168 M | -168 M | -168 M | -137 M | -137 M | -137 M | -137 M | -114 M | -114 M | -114 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
104 M | 109 M | 99.2 M | 106 M | 12.8 M | 14 M | 17.2 M | 22 M | 27.2 M | 33.8 M | 40.3 M | 48.5 M | 54.8 M | 60.5 M | 64.7 M | 16.3 M | 16.3 M | 16.3 M | 16.3 M | 26.5 M | 26.5 M | 26.5 M | 26.5 M | 30.3 M | 30.3 M | 30.3 M | 30.3 M | 52.7 M | 52.7 M | 52.7 M | 52.7 M | 22 M | 22 M | 22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
17.7 M | 21.9 M | 12 M | 17.3 M | 12.1 M | 13.2 M | 7.78 M | 5.19 M | 4.84 M | 7.63 M | 7.45 M | 3.6 M | 7.6 M | 10.7 M | 19.3 M | 7.05 M | 7.05 M | 7.05 M | 7.05 M | 5.31 M | 5.31 M | 5.31 M | 5.31 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 20.7 M | 20.7 M | 20.7 M | - | 3.77 M | - | - | - | 6.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
95.2 M | 101 M | 91.3 M | 98.3 M | 11.2 M | 12.8 M | 14.3 M | 18.6 M | 22.7 M | 28.6 M | 36.1 M | 43.9 M | 50.1 M | 56.1 M | 61.4 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 16 M | 16 M | 16 M | 16 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 47.8 M | 47.8 M | 47.8 M | 47.8 M | 17.9 M | 17.9 M | 17.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
- | - | - | - | 11.2 M | 12.8 M | 14.3 M | 18.6 M | 22.7 M | 28.6 M | 36.1 M | 43.9 M | 50.1 M | 56.1 M | 61.4 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 16 M | 16 M | 16 M | 16 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | 47.8 M | 47.8 M | 47.8 M | 47.8 M | -112 M | -112 M | -112 M | - | -94.3 M | - | - | - | -82 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung